These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 17703334)

  • 21. Oligoarticular and polyarticular JIA: epidemiology and pathogenesis.
    Macaubas C; Nguyen K; Milojevic D; Park JL; Mellins ED
    Nat Rev Rheumatol; 2009 Nov; 5(11):616-26. PubMed ID: 19806151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome in patients with enthesitis related arthritis (ERA): juvenile arthritis damage index (JADI) and functional status.
    Sarma PK; Misra R; Aggarwal A
    Pediatr Rheumatol Online J; 2008 Oct; 6():18. PubMed ID: 18945336
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CLINICAL Review #: the role of receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/osteoprotegerin: clinical implications.
    Vega D; Maalouf NM; Sakhaee K
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4514-21. PubMed ID: 17895323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protease systems and their pathogenic role in juvenile idiopathic arthritis.
    Margheri F; Laurenzana A; Giani T; Maggi L; Cosmi L; Annunziato F; Cimaz R; Del Rosso M
    Autoimmun Rev; 2019 Aug; 18(8):761-766. PubMed ID: 31181328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated serum receptor activator of NFkappaB ligand (RANKL), osteoprotegerin (OPG), matrix metalloproteinase (MMP)3, and ProMMP1 in patients with juvenile idiopathic arthritis.
    Sarma PK; Misra R; Aggarwal A
    Clin Rheumatol; 2008 Mar; 27(3):289-94. PubMed ID: 17703334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis.
    Agarwal S; Misra R; Aggarwal A
    Rheumatol Int; 2009 Jun; 29(8):907-11. PubMed ID: 19052752
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Levels of serum matrix metalloproteinase-3 correlate with disease activity in the enthesitis-related arthritis category of juvenile idiopathic arthritis.
    Viswanath V; Myles A; Dayal R; Aggarwal A
    J Rheumatol; 2011 Nov; 38(11):2482-7. PubMed ID: 21885500
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum levels of the osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, metalloproteinase-1 (MMP-1) and tissue inhibitors of MMP-1 levels are increased in men 6 months after acute myocardial infarction.
    Halapas A; Zacharoulis A; Theocharis S; Karavidas A; Korres D; Papadopoulos K; Katopodis H; Stavropoulou A; Lembessis P; Xiromeritis C; Zacharoulis A; Koutsilieris M
    Clin Chem Lab Med; 2008; 46(4):510-6. PubMed ID: 18298349
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL / osteoprotegerin (OPG) ratio and OPG gene polymorphisms.
    Eid R; Abdelsalam M; Fathy AA; Abolenein HM; Elmarghany EB; El-Hanafy AA; Hamdy N; Abd-Elmagid DS; Niazy NA; Abd-El Ghaffar DM
    Pediatr Rheumatol Online J; 2023 Jun; 21(1):58. PubMed ID: 37328895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Matrix metalloproteinase 1 and 3 genetic variations on susceptibility and severity of juvenile idiopathic arthritis.
    Abd-Allah SH; El-Shal AS; Shalaby SM; Pasha HF; Abou El-Saoud AM; Abdel Galil SM; Mahmoud TA
    IUBMB Life; 2015 Dec; 67(12):934-42. PubMed ID: 26510114
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Osteopenia is common in adult male patients with active juvenile idiopathic arthritis.
    Aggarwal P; Aggarwal A; Gupta S; Misra R
    J Rheumatol; 2006 Aug; 33(8):1642-5. PubMed ID: 16881120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in patients with early rheumatoid arthritis.
    Fiedorczyk M; Klimiuk PA; Sierakowski S; Gindzienska-Sieskiewicz E; Chwiecko J
    J Rheumatol; 2006 Aug; 33(8):1523-9. PubMed ID: 16881109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
    Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
    Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
    Peake NJ; Khawaja K; Myers A; Jones D; Cawston TE; Rowan AD; Foster HE
    Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis.
    Viola S; Felici E; Magni-Manzoni S; Pistorio A; Buoncompagni A; Ruperto N; Rossi F; Bartoli M; Martini A; Ravelli A
    Arthritis Rheum; 2005 Jul; 52(7):2092-102. PubMed ID: 15986372
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.